Tag: ElMindA

[Firefly Neuroscience in GlobeNewswire] STALICLA and Firefly Neuroscience enter partnership agreement for the development of Electroencephalogram (EEG) as a biomarker for subgroups of patients with ASD

Mar 27, 2023 |

Geneva, Switzerland – 27 March 2023, STALICLA SA and Firefly Neuroscience today announced a partnership to further validate EEG-based biomarkers in biologically enriched subgroups of patients with Autism Spectrum Disorder (ASD). This follows the successful completion of STALICLA’s Phase 1b clinical trial for its lead asset STP1 where EEG measurement was shown to be a powerful predictor of efficacy. Read more...

Read More
Your body, disrupted

Your body, disrupted

Aug 28, 2019 | ,

In April, scientists at Tel Aviv University “printed” the world’s first 3D vascularized heart using a patient’s own cells and biological material. This is just the tip of the medical iceberg. We expect healthcare to change in the next decade as disruptive technologies promise to improve patient outcomes, making medicine more personalized, effective, and interconnected. The Path to Personal Care: Genetics How similar do you think you are to a banana? You actually share 60% of your genetic code with this healthy snack. DNA is the core building block of every living thing, and minute changes in genetic codes are responsible for unbelievable differences between us. From 23andMe DNA tests providing personalized reports about your ancestry to Igentify revolutionizing genetic testing and counseling, scientists are harnessing our understanding of genetics to provide real value to society. Medicine still relies heavily on general population statistics. The doctor evaluates your symptoms, considers your age, weight, family health history, and ultimately determines treatment. But far too often we simply do not respond and return to the doctor, having wasted money, effort, and time....

Read More

[ElMindA in PR Newswire] elminda and RI.Group to Form RI.Mind – a Joint Venture to Apply elminda’s Brain Analytics Technology for Personalization of Medical Cannabis

Mar 7, 2019 |

elminda Ltd., a leading brain technology company, and RI.Group Investment Management Ltd., a strategic investor in the fields of agriculture, healthcare and natural resources have teamed up to utilize proven technology to address one of the main challenges of medical cannabis health – personalization. Read more...

Read More

[ElMindA in Globe Newswire] The Villages Health and elminda joint Study Receives Erickson Foundation Award for Excellence in Aging Research at 2018 APHA Annual Meeting

Nov 1, 2018 |

elminda Ltd., an emerging medical technology company dedicated to paving a path to better brain health by integrating big-data repositories, artificial intelligence (“AI”) and machine-learning algorithms with its ground-breaking Brain Network Analytics (“BNA”) platform, is pleased to announce that a manuscript, entitled “Evaluating Brain Health: Early Findings on the Utility of a Novel Technology to Access Brain Health in Late Life,” will receive the prestigious Erickson Foundation Award for Excellence in Aging Research at the upcoming 2018 American Public Health Association (“APHA”) annual meeting being held November 9-17 in San Diego, California.ople. Read more on Globe...

Read More